Template:CCI Guideline Vasoactive Drugs TISS: Revision history

Jump to navigation Jump to search

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

2024 May 15

2024 May 9

2022 March 16

  • curprev 16:2716:27, 2022 March 16Ttenbergen talk contribsm 935 bytes +294 No edit summary
  • curprev 16:2516:25, 2022 March 16Ttenbergen talk contribs 641 bytes +641 Created page with "Both {{TISS w Nr | Vasoactive drug IV continuous-multiple simultaneous (TISS Item)}} and {{TISS w Nr | Vasoactive drug IV continuous-multiple simultaneous (TISS Item)}}: * do '''not include pure antiarrhythmics''' -- by which we mean agents that might not ALSO be used for cardiotonic effects (such as iv beta blockers) * include all vasoactive and cardio-active agents, including: **Catecholamines: norepinephrine, epinephrine, phenylephrine, dopamine **Other vasoconstri..."